HOME >> BIOLOGY >> NEWS
Additional mammogram readers improve breast cancer detection

Mammogram readings by both radiologists and non-physician technologists improve breast cancer detection rates, according to a study in the July 24 Journal of the National Cancer Institute.

Studies have shown that breast cancer detection may increase when mammograms are reviewed by both a radiologist and a mammographic technologist. In The Netherlands, a breast cancer screening program was implemented in the 1990s that required all mammograms be read by two radiologists. Mammographic technologists were also trained to look for abnormalities.

Lucien Duijm, M.D., Ph.D., of Catharina Hospital in Eindhoven, The Netherlands, and colleagues examined whether adding readings by two technologists to the standard examination by two radiologists would improve cancer detection rates and the accuracy of the readings.

The breast cancer detection rate increased 6.8% (from 5.27 to 5.63 cancers per 1,000 women screened) when the mammograms were read by two technologists and two radiologists. And adding two technologists only slightly increased the number of false positives, compared with readings by a pair of radiologists alone.

Our results indicate that all technologist-positive readings should be considered for [further] examination because this subset of screening mammograms shows a high prevalence of breast cancer, the authors write.

In an accompanying editorial, Joann Elmore, M.D., of Harborview Medical Center in Seattle and James Brenner, M.D., J.D., of the University of California, San Francisco discuss the challenges of generalizing the results of the study because of differences in screening programs around the world.

Ultimately, deciding on the number of readers needed to interpret a screening mammogram will depend on how many readers are available and which outcomes we seek, the authors write.


'"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
24-Jul-2007


Page: 1

Related biology news :

1. Combination hormone therapy doubles breast density and quadruples risk of abnormal mammograms
2. New test improves detection of liver cancer
3. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
4. Gene expression pattern could lead to improved treatment of pediatric septic shock
5. New role for protein in fat cells may improve understanding of obesity and diabetes
6. Jefferson scientists patent dramatically improves
7. Cardiac patches stimulate regeneration, improve function after heart attack
8. Co-operation between GSF and clinic improves outlook for sarcoma patients
9. EPA foregoes opportunity to improve nanotechnology oversight
10. Biocontrol of invasive water hyacinth contributes to socioeconomic and health improvements in Africa
11. Kansas, Missouri School Board members to explore improvements in science-related education

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Additional mammogram readers improve breast cancer detection

(Date:5/21/2013)... Illinois at Chicago College of Medicine will study gender differences ... main energy source -- and how changes in fat metabolism ... million, 4-year grant from the National Heart, Lung and Blood ... fuel for energy. These changes may play a major role ... men and women, says E. Douglas Lewandowski, director of the ...
(Date:5/21/2013)... few decades, scientists have developed many devices that can ... While generally effective, each of these treatments has drawbacks, ... study from MIT analyzes the potential usefulness of a ... and drug-releasing stents, but may pose fewer risks. With ... artery for only a brief period, during which it ...
(Date:5/21/2013)... 2013 Royal Philips Electronics (NYSE: PHG, AEX: ... portable ultrasound with Philips, industry leading Live 3D TEE, ... xMATRIX with available Live 3D TEE and ICE will ... the EuroPCR, official meeting for the European Association of ... its launch in 2012, Philips CX50 xMATRIX has been ...
Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
(Date:5/21/2013)... -- First patients dosed with PSX1002, an ... using Prosonix, particle engineering platform Prosonix, an ... Respiratory Medicines by Design , has initiated a ... its effect on lung function and the safety of ... severe chronic obstructive pulmonary disease (COPD). The first two ...
(Date:5/21/2013)... by George Washington University Professor Tianshu Li provide ... small droplets is strongly size-dependent, an important conclusion ... formation of ice at the nanoscale is a ... has important implications for climate research and other ... supercooled water is generally initiated by a process ...
(Date:5/21/2013)... Smarter Security, Inc., provider of premium, innovative ... Genzyme, a Sanofi company and leading biotech company, recently ... a multi-use facility in the United States. With Door ... this latest order underscores the satisfaction and success the ... device improving doorway access control. , “We recommend ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. today ... of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody ... the HER2 oncoprotein," will be presented at the ... Clinical Oncology during the Developmental Therapeutics - Immunotherapy ... 4:15 – 4:30 PM.  The presentation will describe ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: